Showing results (11-20 of 457) with videos related to
Sort By:
Pageof 46
Blood|December 1, 1985
Human placental conditioned medium reverses apparent commitment to differentiation of human promyelocytic leukemia cells (HL60)H von Melchner, K HöffkenJournal of Cancer Research and Clinical Oncology|May 11, 1999
The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approachK O Kliche, K HöffkenBlood|April 1, 1984
T lymphocyte-mediated graft--antigraft reactivity during graft-versus-host reaction in vitroH von Melchner, K HöffkenDeutsche Medizinische Wochenschrift (1946)|May 21, 1976
[Laparoscopy in patients with Hodgkin's disease (author's disease)]K Höffken, C G SchmidtZeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|September 24, 1976
Human chorionic gonadotropin (HCG) in monitoring the course of testicular tumoursK Höffken, C G SchmidtJournal of Cellular Physiology|December 1, 1985
Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potentialH von Melchner, K HöffkenZeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|May 3, 1976
Chemotherapy in stage II testicular tumours: preliminary communicationK Höffken, C G SchmidtMMW Fortschritte Der Medizin|July 18, 2003
[Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient]H G Sayer, K HöffkenAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Formestane in the treatment of advanced postmenopausal breast cancerK Possinger, W Jonat, K HöffkenJournal of Cancer Research and Clinical Oncology|June 30, 1998
Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignanciesR Kath, M Hartmann, K HöffkenPageof 46